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The High Risk Patient After Recovery From Myocardial Infarction:
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Sail Francisco. Caltforma
Patients at high risk for recurrent myocardial infarction
or death can be identified after recovery from an acute
myocardial infarction. Predictors of high risk at the time
of initial hospital discharge ma y var y in different local-
ities depending on the underlying baseline characteristics
of the patient cohort. The medical records were analyzed
of 139 patients discharged from San Francisco General
Hospital aft er recovery fr om an acute myocardial in-
farction between July 1978 and September 1981. Multi-
var iate stepwise discriminant analysis of 20 variables
contr ibuting to sudden and total death identified com-
plex ventr icula r ectopic rh ythm as the most important
var iable, foUowed by age. Failure to receive chronic long-
Risk stratifica tion carried out early in the course of acute
myocardial infarc tion perm its enha nced identification of pa-
tient s who may not survive initia l hospitalization. Such risk
factors include age, pulmonary ede ma, congestive heart fai l-
ure , an enlarged heart , tachycardia , previous myocardial
infarctio n, an anterior infarct ion , infarct extension, pump
failure manifested by hypotension and poor peripheral per-
fusio n, the development of adva nced conduction syste m
disturbances, evidence of large infarction by enzyme anal-
ysis or rad ionucl ide scintigrap hy and preexisting hyperten-
sion (1-9) . Recentl y , factors that identify the patient at high
risk for recurre nt myocardial infarction or death after re-
cove ry from acute myocardial infarc tion have been studied
(10-30) . Recognition of high risk patients may permit spe-
cific interventions to be directed toward the factors responsible.
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acting nitrates was an independent variable contributing
to total mortality but not to sudden death, while the
presence of an initial anterior myocardial infarction and
impaired left ventricular function were independent
variables contributing to sudden death but not to total
mortality. Routine 24 hour ambulatory monitoring,
radionuclide ventr iculogr aphy and submaximal stress
tests performed during the second week after recovery
from an acute myocardial infarction provide identifi-
cation of a high risk cohort for subsequent recurrent
myocardial infarction or death and permit appropriate
interventions designed to lessen ri sk to be undertaken.
Methods
Study patients and their categorization. We reviewed the
medical records of all survivors of an acute myocardial infarction
at San Francisco General Hospital between July 1978 and Sep-
tember 1981 who had 24 hour Holter ambulatory electrocardio-
graphic recordings before discharge; 141 consecutive cases were
identified and 139 of these were successfully followed up for 2
weeks to 36 months (mean ± standard error of the mean 11.0 ±
7.9 months). The occurrence of any new events, changes in med-
ications or relevant data omitted initially from the medical records
were noted. The 24 hour Holter ambulatory recordings were ob-
tained during the second week of hospitalization, usually on the
tenth day. During electrocardiograp hic monitoring. the patient was
encouraged to walk, but no unusual physical activity was under-
taken. For the purpose of this study. the tapes were categorized
according to the classification proposed by Lown and Wolf (3 1).
This classifica tion fails to take frequency of arrhythmia into con-
sidera tion and is hierarchical since. if two or more types of ectop ic
rhythms occur. only the highest classification number. presumably
reflecting the more serious form. is designated . Nevertheless , we
categorize d the patients for statistical purposes in the uncompli-
cated group if Lown class 0 to 2 ectop ic rhythm was observed and
in the complicated or complex group if class 3 to 5 arrhythmia
was present. In addition to the 24 hour Holter recordings. II I of
the 139 patients (8 1% ) underwent tcchnetium-99m albumin gated
cardiac blood pool scans before discharge . Seventy-five patients
(54%) also had submaximal symptom- or sign-limited treadmill
stress tests, or both. just before discharge .
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Analysis of risk variables. Twenty variables were subjected
to univariate analysis for their influence on subsequent nonfatal
myocardial infarction, total mortality and sudden death. Sudden
death was defined as death occurring within I hour of the onset
of symptoms provided that there was no evidence of a fresh, acute
myocardial infarction. The University of California BMDPIL life
tables and survival functions were used for statistical analysis (32).
This program estimates the survival distribution for censored data
when patients enter the study at different times and have different
lengths of follow-up. Cutler-Ederer actuarial-type tables and
Kaplan-Meier product limit estimates were generated. Savage
(Mantel-Cox) statistics were used to assess the significance of
associations. We also carried out multivariate analysis with the
same variables using stepwise discriminant logistic and multiple
linear regression analysis (PIRand P2R). The importance of each
independent variable in predicting outcome was assessed by com-
parison of the relative odds ratio.
The 20 variables selected for analysts were age. sex, location
of infarct, nontransmural versus transmural infarction, peak crea-
tine kinase activity, history of a prior myocardial infarction, history
of angina, history of smoking, hypertension, diabetes mellitus,
congestive heart failure, early ventricular fibrillation, complex ven-
tricular ectopic rhythm on 24 hour ambulatory monitoring after
recovery, conduction system abnormalities, an abnormal submax-
imal exercise stress test before discharge, impaired global ejection
fraction on radionuclide ventriculography after recovery, the use
of antiarrhythmic drugs and the use of long-acting nitrates, digitalis
or antihypertensive medication after recovery.
Table 1. Univariate Analysis of 20 Risk Variables (probability
[p] values)
Nonfatal
Myocardial Sudden Total
Infarction Death Mortality
Sex 011 0.59 028
Anterior mfarct 0.25 0.04* 0.55
Nonlransmural infarct 0.47 0.08 0.32
Previous myocardial infarct 0.03* 029 0.38
History of angina 0.15 0.84 0.79
History of hypertension 0.08 0.86 0.79
Smoking 0.39 066 0.22
Ventncular fibnllation 0.50 070 o 18
Diabetes 0.80 0.20 o 19
Congestive heart failure 0.24 026 0.07
Positive treadmill test 0.20 013 0.64
Conduction disturbance 0.90 0.09 0.04*
Antiarrhythmic agents 0.004* <00001* 0.0001*
Failure to give long-acting
mtrates 0.50 0.03* 0.04*
Digitahs 008 0.12 0.006*
Ejection fraction <0.50 0.14 0.67 0.07
Complex ventncular
ectopic rhythm 0.78 0.003* <00001*
Age 0.37 0002* <0.0001*
Peak creatine kinase 020 0.29 0.14
Antihypertensive drugs 0.16 0.26 0.45
*Indlcates vanables sigruficanr by umvanate analysis
Relative Odds Ratio
Table 2. Variables Contributing Significant Information by
Multivariate Analysis
tality, sudden death and nonfatal myocardial infarction. Ta-
ble 2 lists those variables found to contribute significant
predictive information by multivariate analysis and lists their
relative odds ratio. The sensitivity and specificity of these
variables for the prediction of mortality are presented in
Table 3.
Discussion
Coronary care unit populations vary widely according
to the catchment area of the hospital or medical center.
Similarly, the mortality rate after recovery from acute myo-
cardial infarction depends on the population being studied.
Cohorts with a large incidence of prior myocardial infarction
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Sudden
Deaths
2 12
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P <0.001
4.19
2.82
1.67
Total
Death,
P <0.001
Complex ventricular ectopic rhythm
Age
Failure to grvc nitrates
Ejection fraction <0.50
Antenor infarction
Significance of logistic analysis
Results
Follow-up mortality. Twenty-five deaths occurred among
our cohort of 139 patients during the course of this follow-
up study. Of these, 13 were classified as sudden deaths.
The 1 year overall mortality rate by life insurance actuarial
analysis was 18%.
Fifty-one patients exhibited complex ectopic rhythm (Lown
class 3 to 5) on predischarge Holter monitoring. Among the
43 patients in this subgroup whose global ejection fraction
was measured, 25 had a value of less than 0.50. Ten deaths
occurred among these 25 patients; six of these were sudden.
There were only four deaths among the 18 patients with
complex ectopic rhythm and an ejection fraction of 0.50 or
greater and only one of these was sudden. Six deaths oc-
curred among the 88 patients who had no evidence of com-
plex ventricular ectopic rhythm on predischarge Holter mon-
itoring, and only three of these were sudden. Among the
26 patients with uncomplicated ectopic rhythm and an ejec-
tion fraction of less than 0.50, only two deaths occurred.
one of which was sudden. One death (sudden) occurred
among the 42 patients with uncomplicated ectopic rhythm
and a normal ejection fraction, while the three remaining
deaths in the group with uncomplicated ectopic rhythm were
among patients whose ejection fraction was not measured.
Predictive risk factors. Table I lists the significance of
each variable examined by univariate analysis for total mor-
PROGNOSIS AFrER MYOCARDIAL INFARCTION J AM COLL CARDIOL
19S3.1(2) 39 1-400
393
Table 3. Prediction of Mortality by Stepwise
Discriminant Analysis
Actual Group
Total Deaths Sudden Deaths
Dead Ahve Dead Alive
Predicted group
Dead 23 28 I I 26
Alive 5 83 2 100
Sensitivity 82% 115o/c
Specificity 75% 79o/c
and older patients have a higher late mortality rate. The
variability of different patient popul ations is illustrated by
a comparison of two recently compl eted randomized clinical
trials on the use of beta-adrenergic blocking drugs after
recovery from acute myocardial infarc tion. In the Swedi sh
metoprolol study, the mortality rate at 90 days was ap-
proximately the same as that at I year in the placebo group
in the National Heart . Lung , and Blood Institut e mult icenter
propranolol trial (33 ,34). Our patients at San Francisco Gen-
eral Hospital are generally older and have a relati vely large
incidence of prior myocardi al infarction. Survival at I year
was 90% for patients younger than age 49 years, 93% for
patient s 50 to 59 years old and 83% for patients 60 to 69
years old . However , for the 33 patients older than 69 years,
the I year survival rate was only 60%, which may help to
explain the 18% I year mortality rate among the 139 con-
secutive patients in this study. This figure is somewhat higher
than that generally reported and reflects an overall high risk
popul ation. Nevertheless, subsets of pat ients at higher and
lower risk can be identified in this population.
In recent years we have routin ely studied our patients 8
to 10 days after the onset of their infarct with a multigated
radionucl ide angiogram , a submaximal (70% of pred icted
maximum) symptom- or sign-limited treadmill stress test
and 24 hour ambulatory monitorin g. The se three nonin va-
sive procedures are of considerable value in identifying a
cohort at high risk for recurrent infarction and death. Fur-
thermore , the information obtained from these evaluati ons
helps in determining management after recovery.
24 Hour Ambulatory Predischarge
Holter Monitoring
Predictive role of complex ventricular ectopic
rhythm. All 139 patients in this study underwent 24 hour
ambulatory electrocardiographic monitoring. The presence
of complex ventricular ectopic rhythm proved to be the
variabl e with the greatest influence on subsequent survival.
Figure I illustrates the effect of complex ventricular ectopic
rhythm on total mortality using the life insurance actuarial
format. The I year surv ival rate was 66% among patients
who had complex ectopic rhythm. compared with 94% among
those with uncomplicated ectopic rhythm (p < 0.002).
Role of chronic antiarrhythmic drug therapy. The
chronic use of oral anti arrh ythmic drugs correlated with a
significant risk for all three end point s: total mortality, sud-
den death and nonfatal myocardial infarction . Figure 2 com-
pares total mortality among patients who were and were not
taking antiarrhythmic drugs. Paradoxically , the mortality
rate was significantly higher among the patient s taking these
agents. Th e result s are almost identical to the relation be-
tween complex ectopic rhythm and mortalit y shown in Fig-
ure I . One can only spec ulate what the mortality rate would
have been had no antiarrh ythm ic agents been given : one
might also speculate whether the addition of the antiar-
rhythmic agent was actually harmful rather than beneficial.
Clearly, simply adding a type I antiarrhythmic agent without
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Figure 2. Univariate analysis of the relation be-
tween antiarrhythmic drug use and survival. The
high mortality rate in the group receivmg anti-
arrhythmic drugs presumably reflects the high
nsk group receiving these agents.
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evaluating its immediate and long-term effects is inade-
quate. When multivariate analysis was carried out for both
total mortality and sudden death (Table 2) to eliminate com-
plicating variables, the important predictive role of complex
ventricular ectopic rhythm was again demonstrated. How-
ever, the use of antiarrhythmic agents was not an indepen-
dent variable and provided no additional information beyond
that reflected by complex ventricular ectopic rhythm alone;
that is, the high mortality rate associated with the use of
antiarrhythmic drugs undoubtedly reflected the high risk
status of the patients receiving these drugs.
Other prognostic variables. Stepwise discriminant
analysis on the influence of all variables on total mortality
showed that only complex ventricular ectopic rhythm, fail-
ure to administer chronic long-acting nitrates and age pro-
vided independent significant information. We carried out
the same analysis for sudden death. In addition to complex
ventricular ectopic rhythm, which was still the most im-
portant single variable, age, the presence of an anterior
infarction and impaired left ventricular function were also
independently significant prognostic variables.
Previous studies. Many studies have shown an asso-
ciation between ventricular ectopic rhythm after recovery
from myocardial infarction and subsequent mortality
(12,18,22,27,29,30,35-38). In most of these studies, am-
bulatory recordings of I to 12 hours' duration were used.
Schulze et al. (36), at Johns Hopkins Hospital, emphasized
the importance of complex ventricular ectopic rhythm. They
performed both 24 hour ambulatory monitoring and nuclear
ventriculography approximately 2 weeks after hospital ad-
mission of their patients with infarction. The projected I
year mortality rate was 64% when complex ectopic rhythm
was present and 31% in patients with an ejection fraction
of less than 0.40. In contrast, we found a I year mortality
rate of 34% among patients with complex ectopic rhythm
at discharge and 22% among those with an ejection fraction
of less than 0.50. These differences in projected survival
may reflect differences in baseline characteristics of the two
cohorts. Furthermore, we had 139 patients with a mean
follow-up time of II months (range 0.5 to 39), whereas
Schulze et al. reported on 81 patients with a mean follow-
up time of 7 months. Finally, only 8% of their patients with
Lown class 3 to 5 ectopic rhythm had an ejection fraction
of 0.40 or greater, whereas 30% of our patients with com-
plex ventricular ectopic rhythm had an ejection fraction
greater than 0.50 and 36% had complex ectopic rhythm and
an ejection fraction greater than 0.40. Thus, the major dif-
ference was our observation that complex ectopic rhythm
occurs with some frequency in the presence of good left
ventricular function. Complex ventricular arrhythmia need
not be a hallmark of impaired left ventricular dysfunction,
although it is more commonly seen in that setting. Patients
with complex ectopic rhythm and good left ventricular func-
tion are also a higher risk subgroup.
Role of left ventricular dysfunction versus complex
ectopic rhythm. Although the results of Schulze et al. and
our own results suggest that the prognosis in patients with
complex ventricular ectopic rhythm is worse than that ex-
pected from impaired left ventricular function, a later study
by Taylor et al. (37), also at Johns Hopkins Hospital, did
not confirm this observation. In a combined angiographic,
clinical, electrocardiographic and contrast ventriculographic
study, prospective data were accumulated in 106 patients
for up to 30 months. Stepwise discriminant analysis showed
that prior myocardial infarction and a reduced ejection frac-
tion best predicted late mortality. Specifically, complex ven-
tricular arrhythmias during the late hospital phase did not
provide additional independent prognostic information. This
difference between our results and those reported by Taylor
et al. is somewhat difficult to reconcile. The most obvious
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difference was that their study was confined to patients who
were younger than 65 years of age, whereas 33 of our patients
were older than 69 years of age . In our study, a history of
prior myocardial infarction was significant by univariate
analysis for recurrent myocardial infarction but did not pro-
vide additional information by univariate or multivariate
analy sis for mortality, as was observed in the study of Taylor
et al. from Johns Hopkins Hospital. Furthermore, II of
their 13 patients who died (85%), died suddenly, whereas
only 46 % of the deaths in our study were sudden . These
differences, of course, may also reflect other baseline dif-
ferences in the patient cohorts. However, complex ventric-
ular ectopic rhythm must be considered <t serious finding
regardless of left ventricular function . In light of the present
state of our knowledge, attempts to suppress complex ven-
tricular ectopic rhythm after recovery from a myocardial
infarction seem appropriate. This view is supported by the
experience of Graboys et al. (39), who recently demon-
strated long-term survival of patients with malignant ven-
tricular arrhythmias treated with antiarrhythmic drugs . Sixty
percent of their patients had underlying coronary heart dis-
ease and 84% of this group had sustained an earlier myo-
cardial infarction .
Approach to antiarrhythmic drug therapy. We use
ambulatory monitoring to identify patients who are at high
risk for late events and who might respond favorably to
antiarrhythmic drugs. In patients with complex ectopic rhythm,
we generally administer drugs designed to suppress the ar-
rhythmia. During the time the data in Figure I were being
accumulated, we were less concerned with tailoring the
antiarrhythmic therapy specifically to demonstrate suppres-
sion of ectopic rhythm on follow-up ambulatory electro-
cardiographic recordings. Recently , we have taken more
care to find antiarrhythmic agents that will specifically sup-
press the patient's ectopic rhythm. In general, we have used
the approach suggested by Lown and Graboys (40) in the
management of recurrent ventricular tachycardia. We give
half of the daily maintenance dose of an oral antiarrhythmic
agent and observe its effect over 6 hours . During this time ,
the patient is subjected to ambulation and low level stress
in an attempt to induce ectopic rhythm . If necessary , we
repeat this procedure on succe ssive days with other antiar-
rhythmic drugs , searching for a drug that significantl y sup-
presses the complex ectopic rhythm . The patient's response
to therapy is followed over the ensuin g months with repeat
24 hour ambulatory electrocardiograms. Nevertheless, our
early practice of arbitrarily treating the patient with a class
I antiarrhythmic agent (generally quinidine or procainam-
ide) probably did not prevent death .
The use of antiarrhythmic agents in patients who have
recovered from an acute myocardial infarction has been
evaluated in several studies. Randomized, double-blind
studies have not shown that antiarrhythmic agents are ben-
eficial (41). However, most of these studies focused on all
patient s who recovered from myocardial infarction rather
than randomizing only those who had complex ventricular
arrhythmia after recovery. A large scale, randomized, dou-
ble-blind trial is needed to test the effects of specific an-
tiarrhythmic drugs in the high risk patient subgroup with
complex ventricular ectopic rhythm after recovery from an
acute myocardial infarction .
Nuclear VentricuLography
Prognostic and therapeutic applications. The rapid
development of computerized nuclear medicine equipment
has furthered noninvasive techniques for evaluating left ven-
tricular function. Now we perform radionuclide ventricu-
lography routinely just before hospital discharge. It is prog-
nostically and therapeutically important to evaluate left
ventricular function. Multivariate analysis of our data re-
vealed that impaired left ventricular function in patients after
infarction was associated with sudden death but not with
overall mortality. In addition to prognostic value, the pres-
ence of impaired global left ventricular function may influ-
ence the timing of coronary arteriography months or years
later ; should a patient develop chronic stable angina pectoris
after recovery from myocardial infarction, the presence of
known left ventricular dysfunction encourages us to perform
coronary arteriography without further noninvasive tests.
This practice is based on extrapolation of data from studies
of patient s with chronic stable angina pectoris associated
with two or three vessel disease and impaired left ventricular
function whose chance of long-term survival appears to be
better with surgical than with medical management. In our
judgment, however, impaired left ventricular function in an
asymptomatic postinfarction patient does not justify per-
forming coronary bypass surgery . We do not perform rou-
tine coronary arteriography solely because left ventricular
dysfunction is demonstrated by radionuclide ventriculog-
raphy ; nor is impaired left ventricular function the basis for
withholding beta-adrenergic blocking drugs or prescribing
digitalis in the postinfarction patient. Most patients without
clin ical evidence of conge stive heart failure respond quite
well and are not made worse clinicall y by the use of beta-
adrenergic blocking drugs.
Role of therapy with beta-adrenergic blocking
drugs. Whether the chronic administration of beta-adren-
ergic blocking drugs after recovery from myocardial in-
farction protects against sudden death or recurrent myo-
cardial infarction has been controversial. Some early studies
were questioned because of design limitations, particularly
inadequacy of the sample size . Recently , three large , dou-
ble-blind , randomized studies of metoprolol , timolol and
propranolol were carried out (33, 34 ,42). Each drug signif-
icantly reduced mortality. The mortality rate is reduced by
about 25% up to 2 years after myocardial infarction in pa-
tients who can be given beta-adrenergic blocking drugs. The
mechanism of this protection is unknown. Beta-adrenergic
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blocking drugs reduce the frequency and complexity of ven-
tricular arrhythmia, but to what extent this antiarrhythmic
effect is the mechanism of protection or to what extent it
simply reflects the anti-ischemic effects of the drug is un-
known, Nevertheless, administration of beta-adrenergic
blocking drugs should be started before hospital discharge
in the absence of overt congestive heart failure or severe
chronic obstructive lung disease,
Role of digitalis therapy. In contrast to beta-adrenergic
blocking drugs, digitalis may be harmful when administered
to patients who have recovered from a prior myocardial
infarction. Bigger et al. (38) analyzed the 24 hour electro-
cardiographic recordings obtained in 430 patients approxi-
mately 2 weeks after their admission to a coronary care unit
for acute myocardial infarction; they followed the patients'
outcome for at least 1 year, The 200 patients discharged on
digitalis therapy were 4.5 times as likely to die within the
year as those who did not receive digitalis. In this series,
it appeared that digitalis increased both the prevalence of
repetitive ventricular premature depolarizations and cardiac
mortality when other risk factors were controlled by statis-
tical techniques. Moss et al. (43) evaluated the effect of
digitalis on cardiac mortality at 4 months after hospital dis-
charge following recovery from acute myocardial infarction
in 812 patients. A mortality rate of 38.5% was observed in
this period among patients receiving digitalis who had
congestive heart failure in the coronary care unit and ex-
hibited complex ventricular ectopic rhythm on a predis-
charge 24 hour ambulatory electrocardiographic recording.
The extremely high mortality rate suggests that digitalis
increased mortality above that expected when adjusting for
the presence of more severe underlying heart disease com-
pared with findings in patients who were not receiving digitalis,
One can only speculate on the mechanisms by which
digitalis might increase mortality in postmyocardial infarc-
tion patients. Among the potential mechanisms are an en-
hanced potential for digitalis-induced ventricular arrhyth-
mias, an increase in the frequency of existing ectopic foci,
the aggravation of digitalis toxicity by digitalis/quinidine
interactions in some and the possibility that complex ven-
tricular ectopic rhythm in those patients with congestive
heart failure reflected more severe underlying myocardial
damage than in those without congestive failure. In any
case, it would appear that the use of digitalis should be
cautiously weighed in those patients with heart failure who
demonstrate complex ventricular ectopic rhythm, The al-
ternative of managing such patients solely with afterload
reducing agents and diuretic drugs may be advisable until
such time as the role of digitalis is further clarified in this
subset of patients.
Reduced ejection fraction and congestive failure. The
presence of a reduced ejection fraction and a history of
congestive heart failure before admission or at discharge
tended to be associated with increased total mortality by
univariate analysis (84 versus 76% at 12 months); however,
this finding was of borderline statistical significance (p =
0.07). When such data were examined with multivariate
analysis, neither a reduced ejection fraction, the presence
of congestive heart failure nor the administration of digitalis
added unique information beyond that contributed by the
presence of complex ventricular ectopic rhythm, although
such arrhythmia was more commonly found in patients with
impaired left ventricular function.
Anterior versus inferior infarction. Anterior, con-
trasted with inferior, myocardial infarction was associated
with a greater likelihood of sudden death but not total death
(Table 2). An anterior site of infarction more often results
in a larger infarction than does an inferior site, This finding
might appear to explain the difference in observed likelihood
of sudden death. However, multivariate analysis showed
that both an anterior infarction and impaired left ventricular
ejection fraction were independently significant variables.
It is of interest that none of the 13 patients who died suddenly
in this study had an inferior myocardial infarction as their
original index event; all 13 had either a transmural or a
nontransmural anterior infarct.
Role of pulmonary edema. Warnowicz et al. (44) ana-
lyzed 39 consecutive patients with acute pulmonary edema
and myocardial infarction in our unit at San Francisco Gen-
eral Hospital. Over a mean follow-up period of 9 months,
11 patients died. Mortality was not influenced by the status
of the left ventricle at the time of discharge as analyzed by
radionuclide ventriculography, This experience suggests that
pulmonary edema in acute myocardial infarction may occur
even when the infarct does not result in a large area of
irreversible damage. Furthermore, these patients represent
a high risk group for recurrent infarction and sudden death.
We believe the following is the most likely explanation
for this sequence of events: The initial infarct not only re-
quires the rest of the myocardium to maintain normal ven-
tricular stroke work, but also imposes an additional burden
on the uninfarcted myocardium as a result of the outpouring
of catecholamines and, not uncommonly, the presence of
tachycardia. If the residual myocardium not involved by the
infarct is supplied by coronary vessels with significant ob-
structive lesions, it may become functionally dyskinetic or
even akinetic under the stress of an increased myocardial
oxygen demand. The combined effects of infarcted myo-
cardium and reversibly akinetic myocardium may result in
acute left ventricular failure, The pulmonary edema, with
management often including nitrates in this circumstance,
usually responds readily. Patients with this condition, on
recovery from the infarction, may have normal global func-
tion. Nevertheless, they clearly have a large area of addi-
tional myocardium still at jeopardy, as evidenced by the
high tendency toward recurrent infarction or sudden death,
Therefore, we believe that patients with pulmonary edema
accompanying acute myocardial infarction and normal global
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left ventricular function on recovery should be studied with
coronary arteriography at or soon after discharge. If sig-
nificant disease is present in two or three vessels suppl ying
viable myoc ardium, bypass surgery should be performed .
Submaximal Stress Test
Predictive va lue. Only 75 of our 139 patient s had a
predischarge submaximal stress test. We did not routinel y
perform submaximal exerci se tests at the retrospective start-
ing date of this study when we were obtaining 24 hour
ambulatory monitoring tapes on all of our patients . In ad-
dition, some patients were excluded because of specific
contraindications to treadmill exercise testing. When we
examined the incidence of subsequent nonfatal myocardial
infarction in those who had undergone treadmill testing , we
found no predicti ve value of low level stress testing in this
small series . Only I of 32 patients who had ST segment
depre ssion of I mm or more had a nonfat al myocardial
infarction , compared with four nonfatal infarction s among
the remaining 43 patients who had negative stress tests. A
similar lack of corre lation with positive submaximal stress
testing was observed in our data by both univariate and
multivariate analysis for total mortality and sudden death .
Weld et al. (26) also failed to show that exercise-induced
ST segment depression and low level exercise testing 2
weeks after an acute myocardial infarction were significantly
associ ated with I year mortality. However, our statistical
analysis was based on the presence or absence of I mm or
more ST segment depre ssion and did not consider other
responses , such as premature termination of exercise due to
exercise-induced ventricular ectopic rhythm , marked ST
segment depre ssion (2 mm or greater), angina, fatigue or
hypotension .
Indications. Submaximal exercise stress tests of pa-
tients who have recovered from an acute myocardi al in-
farction and are ready to be discharged from the hospital
have proved useful in making management decisions. We
exclude patients who have had chest pain within the last
several days. cannot exe rcise on a treadmill because of
locomotive probl ems or have congestive heart failure . evi-
dence of cont inuing poorly controlled atr ial and ventricular
arrhythmias, sinus tachycardia at rest , serious hypertension
or advanced age. Otherwise, the procedure can be carried
out safely. We routinely perform a heart rate-limited test
with a target rate of 120 beats/min , but we stop sooner if
the patient has significant chest pain, severe shortness of
breath , seve re ST segment depre ssion . hypotension or evi-
dence of complex ventri cular ectopic rhythm.
Prognostic value of ST depression. The presence of
ST segment depression has long-term prognostic value. Not
only does its presence correla te with reduced longe vity ove r
the first 2 years after recovery from myocardial infarction ,
but also marked ST segment depression (> 2 mm) is a
particularly poor prognostic sign. In a recent study, 40% of
the patient s with more than 2 mm of ST segment depression
had recurrent infarction or died durin g the first 2 years after
infarction (45).
A normal low level stress test after recovery from a
myocardial infarction sugges ts a good outlook. Starling et
al. (46) reported a 6% incidence rate of recurrent infarction
and no deaths amon g 48 patients who responded norm ally.
In contrast, among those who had ST segment depre ssion.
15% had a recurrent infarction and 10% died . Koppes et
al. (47) and Theroux et al. (48) reported similar experien ces
among normal responders. Furtherm ore, patients who com-
plete a submaximal exerc ise stress test have less coronary
vascular disease as demonstrated angiographically than do
patients who cannot compl ete the test because of ST segment
changes, chest pain or ventricular arrhythm ias (49).
Indications for coronary angiography. We consider
the following to be indications for performing coronary ar-
terio graphy: 2 mm or more of ST segment depression during
submaximal exercise testing early after recovery from myo-
cardia l infarction, the development of hypotension and the
development of angin a dur ing the stress test. These findings
indicate a high likelih ood of multivesse l coronary artery
diseas e . Should signific ant disease of two or three vessels
feedin g viable myocardium be confirmed . we advocate early
coronary bypass surgery.
Thallium stress testing. We are using thallium-20 I
scintigraphy more often durin g the submaximal treadm ill
test . The presence of both a positive exercise stress test and
a reversible perfu sion defect with thall ium scintigraphy has
a predicti ve accuracy of almost 100%. In addition , patients
undergoing stress testing after myocardial infarction fre-
quently have residual electrocardiographic abnormalities or
are tak ing drugs that may complicate interpretation of the
electrocardiographic changes with stress testing .
Role of coronary bypass surgery. An important ques-
tion today is the role of coronary bypass surgery in the
routine management of patients after myocardial infarction .
Data in this area are scarce . A retrospective study at the
University of Alabam a comparing conventional medical
management with bypass surgery after recovery from myo-
cardial infarct ion failed to show a statistically significant
increa se in survival, although a trend toward benefit was
demonstrated (50). A randomized trial comparing surgical
with medical management was carried out in New Zealand
amon g )00 survivors of myocardi al infarction who met the
criteria of few or no symptoms and coro nary vesse ls that
were suitable for bypass surgery (5 1). After a mean follow-
up period of 4.5 years, no significant difference s in survival
were demonstrated between the two groups; the overall an-
nual mortality rate was 3 to 4% for all patients. Th is study
preselected relati vely low risk patients; patient s with overt
cardi ac failure were not included. Most of the patients were
asymptomatic or minim ally symptomatic and all were youn-
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ger than 60 years of age. Clearly, more data are needed in
this area, particularly in high risk patient subsets. In the
interim, what is prudent practice in relation to bypass sur-
gery in patients after recovery from myocardial infarction?
Indications for surgery. First, we believe that patients
who have acute pulmonary edema early in the course of an
acute myocardial infarction and, on recovery, have normal
global myocardial function may have a large segment of
their myocardium susceptible to reversible ischemia. These
patients should undergo coronary arteriography regardless
of their symptoms. If severe obstructive two or three vessel
disease or left main coronary disease is present, seemingly
jeopardizing a large area of viable myocardium, early cor-
onary artery bypass surgery should be carried out. Further-
more, patients who have postinfarction angina during their
hospitalization for an acute myocardial infarction should
undergo coronary arteriography. We try to postpone this for
several weeks because, if surgery is warranted, it should be
performed at least 4 weeks after the initial attack. However,
continuing postinfarction angina despite maximal medical
management may require earlier study and surgery. We have
been impressed that the incidence of postinfarction angina
has increased and that it is more often seen as a complication
of nontransmural than of transmural infarction. It is tempting
to speculate that early in the course of infarction, the use
of large amounts of nitrates, sometimes with concomitant
beta-adrenergic blocking drugs, may salvage ischemic myo-
cardium that might otherwise undergo necrosis. These por-
tions of myocardium may be left critically jeopardized and
susceptible to recurrent infarction or serve as a future nidus
for sudden cardiac arrest. In our study the univariate as-
sociation between sudden death and nontransmural myo-
cardial infarction approached significance (p = 0.08). Pa-
tients with nontransmural myocardial infarction may also
be susceptible to unstable angina after their recovery. They
become a difficult medical management problem for they
often have recurrent chest pain in the days and weeks after
the onset of their myocardial infarction. We try to wait for
at least 2 weeks before performing coronary arteriography,
although at times we must perform it earlier, with a view
toward early coronary bypass surgery if chest pain fre-
quently recurs despite the use of large amounts of nitrates,
beta-adrenergic blocking agents and calcium channel blockers.
Beneficial role of chronic nitrate administration. An
unexpected finding was the relation of chronic nitrate admin-
istration after recovery to subsequent total mortality and
sudden death. Univariate analysis for both sudden death and
total mortality revealed a significant reduction of mortality
in patients receiving nitrates. Nitrates were generally ad-
ministered either because the patient had been receiving
them before infarction, and therefore they were continued
after recovery or because the patient had postinfarction an-
gina. Thus, a higher mortality rate among patients who were
taking nitrates was expected; instead, the mortality rate was
lower. Multivariate analysis indicated that the failure to
receive long-acting nitrates served as an independent vari-
able favoring subsequent death. In light of these observa-
tions, one might wonder whether chronic nitrate adminis-
tration has an anti-ischemic effect in patients recovered from
an acute myocardial infarction that serves to protect against
subsequent mortality. Failure to receive nitrates did not in-
fluence the likelihood of recurrent nonfatal myocardial in-
farction. These preliminary findings raise the question of a
potential beneficial effect from routine use of nitrates after
a myocardial infarction and indicate a need for further stud-
ies of long-acting nitrates in survivors of myocardial in-
farction in the absence of specific indications for this
medication.
Conclusions
Many groups have followed the outcome of their patients
discharged after recovery from an acute myocardial infarc-
tion and have correlated outcome with a variety of variables
at the time of initial hospital discharge. Predictive variables
have varied somewhat among different studies, probably
owing to differences in original baseline characteristics in
the patient populations. The data from 139 consecutive pa-
tients who had 24 hour ambulatory electrocardiographic
monitoring before discharge from San Francisco General
Hospital between 1978 and 1981 after recovery from myo-
cardial infarction were subjected to both univariate and mul-
tivariate analysis. Complex ventricular ectopic rhythm and
age provided independent information in predicting subse-
quent mortality. However, impaired global left ventricular
function and an initial anterior myocardial infarction were
also predictive for sudden death but not total mortality. In
contrast, failure to receive long-acting nitrates after hospital
discharge was a risk for total mortality but not sudden death.
A common theme running through most studies suggests
that continuing ischemia, impaired left ventricular function,
and complex ventricular arrhythmias, or combinations of
these factors, subject the patient to a high risk of dying
during the first year. Routine performance of radionuclide
ventriculography, 24 hour ambulatory electrocardiographic
monitoring and low level stress testing before hospital dis-
charge permit identification of the high risk patient and
allows a rational therapeutic approach to be undertaken.
We gratefully acknowledge the assistance of Gunnar Modin, BS in ana-
Iyzmg the statistical data.
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